The cholesterol active pharmaceutical ingredient market is poised for steady growth, with its valuation expected to increase from USD 280.6 million in 2023 to USD 445.3 million by 2033. This growth represents a Compound Annual Growth Rate (CAGR) of 4.7% over the next decade, according to a recent report by Future Market Insights. With over …